Speech disorders in patients with Parkinson's disease;Storungen des sprechens bei Parkinson-patienten

Wiener Klinische Wochenschrift

Volumn 110, Issue 8, 1998, Pages 279-286

  Kerschan, Katharina ^a   Pankl, Wolfgang ^b   Auff, Eduard ^c  

^a Univ Klin fur Phys Med/Rehab

^b Abteilung für Neurologie

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Dysarthria; Parkinson's disease; Speech therapy

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DYSARTHRIA; DYSPHONIA; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; PARKINSON DISEASE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SPEECH ARTICULATION; SPEECH DISORDER; SPEECH THERAPY; TREATMENT OUTCOME; MULTIMODALITY CANCER THERAPY; PATIENT CARE; PSYCHOLOGICAL ASPECT;

COMBINED MODALITY THERAPY; DYSARTHRIA; HUMANS; PARKINSON DISEASE; PATIENT CARE TEAM; QUALITY OF LIFE; SPEECH DISORDERS; SPEECH THERAPY;

EID: 0032562293     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Langton Hewer R (1993) The epidemiology of disabling neurological disorders. In: Greenwood R, Barnes MP, McMillan TM, Ward CD (eds) Neurological rehabilitation. Churchill-Livingstone, Edinburgh, pp 3-12
2. Martin WE, Loewenson RB, Resch JA, Baker AB (1973) Parkinson's disease: clinical analysis of 100 patients. Neurology 23: 783-790
3. Logemann JA, Fisher HB (1981) Vocal tract control in Parkinson's disease: phonetic feature analysis of misarticulations. J Speech Hear Disord 46: 348-352
4. Logemann JA, Fisher HB, Boshes B, Blonsky ER (1978) Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord XLIII: 47-57
5. Vieregge P, Dethlefsen J (1992) Krankengymnastik und Logopädie beim Parkinson-Syndrom - eine Bestandaufnahme. Fortschr Neurol Psychiat 60: 369-374
6. Hartelius L, Svensson P (1994) Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey. Folia Phoniatr Logop 46/1: 9-17
7. Mutch WJ, Strudwick A, Roy SK, Downie AW (1986) Parkinson's disease: disability, review and management. BMJ 293: 675-677
8. Sarno MT(1968) Speech impairment in Parkinson's disease. Arch Phys Med Rehabil 49: 269-275
9. Duvoisin RC (1982) Parkinson's disease: a guide for patient and family. Raven Press , New York
10. Estenne M, Hubert M, De Troyer A (1984) Respiratory-muscle involvement in Parkinson's disease. NEJM: 1516
11. Solomon NP, Hixon TJ (1993) Speech breathing in Parkinson's disease. J Speech Hear Res 36/2: 294-310
12. Tzelepis GE, Mc Cool FD, Friedmann JH, Hoppin FG Jr (1988) Respiratory muscle function in Parkinson's disease. Am Rev Respir Dis 138/2: 266-271
13. Murdoch BE, Chenery HJ, Bowler S, Ingram JC (1989) Respiratory function in Parkinson's subjects exhibiting a perceptible speech deficit: a kinematic and spirometric analysis. J Speech Hear Disord 54/4: 610-626
14. Hovestadt A, Bogaard JM, Meerwaldt JD, van-der-Meche FG, Stigt J (1989) Pulomary function in Parkinson's disease. J Neurol Neurosurg Psychiat 52/3: 329-333
15. Boogaard JM, Hovestadt A, Meerwaldt J, v. d. Meche FG, Stigt J (1989) Maximal expiratory and inspiratory flow-volume curves in Parkinson's disease. Am Rev Respir Dis 139 3: 610-614
16. Izquierdo AJL, Jimenez FJ, Cabrera-Valduivia F, Mansilla-Lesmes M (1994) Airway dysfunction in patients with Parkinson's disease. Lung 172/1: 47-55
17. de-Bruin PF, de-Bruin VM, Lees AJ, Pride NB (1993) Effects of treatment on airway dynamics and respiratory muscle strength in Parkinson's disease. Am Rev Respir Dis 148 (6 PT 1): 1576-1580
18. Zupnick HM, Brown LK, Miller A, Moros DA (1990) Respiratory dysfunction due to L-Dopa therapy for Parkinsonism: diagnosis using serial pulmonary function tests and respiratory inductive plethysmography. Am J Med 89: 109-114
19. Leopold NA, Kagel MC (1997) Laryngel deglutition movement in Parkinson's disease. Neurology 48: 373-376
20. Canter GJ (1963) Speech characteristics of patients with Parkinson's disease: I. intensity, pitch, and duration. J Speech Hear Disord 28: 221-229
21. Darley FL, Aronson AE, Brown JR (1969) Differential diagnostic patterns of dysarthria. J Speech Hear Disord 12: 246-269
22. Ackermann H, Hertrich I (1995) Rehabilitation von Sprech- und Stimmstörungen beim Parkinson-Syndrom. Forum Neuroreha: 7
23. Gentil M, Pollak P, Perret J (1995) La dysarthrie parkinsonienne. Rev Neurol Paris 151/2: 105-112
24. Rosenfield DB, Barroso AB (1991) Dysarthria, dysfluency, dysphonia. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD (eds) Neurology in clinical practice. Butterworth, Stoneham, Massachusetts, pp 129-141 (new edition 1996)
25. Ackermann H, Ziegler W (1991) Articulatory deficits in parkinsonian dysarthria: an acoustic analysis. J Neurol Neurosurg Psychiat 54: 1093-1098
26. Svensson P, Henningson C, Karlson S (1993) Speech motor control in Parkinson's disease: a comparison between a clinical assessment protocol and a quantitative analysis of mandibular movements. Folia Phoniatr 45: 157-164
27. Forrest K, Weismer G, Turner GS (1989) Kinematic, acoustic and perceptual analyses of connected speech produced by parkinsonian and normal geriatric adults. J Acoust Soc Am 85: 2608-2622
28. Connor NP, Abbs JH, Cole KJ, Gracco VL (1989) Parkinsonian deficits in serial multiarticulate movements for speech. Brain 112 (Pt 4): 997-1009
29. Forrest K, Weismer G (1995) Dynamic aspects of lower lip movement in parkinsonian and neurologically normal geriatric speakers' production of stress. J Speech Hear Res 38/2: 260-272
30. Netsell R, Daniel N, Celesia GG (1975) Acceleration and weakness in parkinsonian dysarthrias. J Speech Hear Disord 40: 467-480
31. Caligiuri MP (1987) Labial kinematics during speech in patients with parkinsonian rigidity. Brain 110 (Pt 4): 1033-1044
32. Caligiuri MP (1989) The influence of speaking rate on articulatory hypokinesia in parkinsonian dysarthria. Brain Lang 36/3: 493-502
33. Hunker CJ, Abbs JH, Barlow SM (1982) The relationship between parkinsonian rigidity and hypokinesia in the orofacial system: a quantitative analysis. Neurology 32: 755-761
34. Ackermann H, Konczak J, Hertrich I (1997) The temporal control of repetitive articulatory movements in Parkinson's disease. Brain Lang 56: 312-319
35. Canter GJ (1965) Speech characteristics of patients with Parkinson's disease: III. Articulation, diadochokinesis, and over-all speech adequacy. J Speech Hear Disord 30: 217-224
36. Connor NP, Lidlow CL, Schulz GM (1989) Stop consonant production in isolated and repeated syllables in Parkinson's disease. Neuropsychol 27/6: 829-838
37. Ackermann H, Hertrich I, Hehr T (1995) Oral diadochokinesis in neurological dysarthrias. Folia Phoniatrica Logop 47: 15-23
38. Kreul EJ (1972) Neuromuscular control examination (NMC) for parkinsonism: vowel prolongations and diadochokinetic and reading rates. J Speech Hear Disord 15: 72-83
39. Ackermann H, Gröne BF, Hoch G, Schönle PW (1993) Speech freezing in parkinson's disease: a kinematic analysis of orofacial movements by means of electromagnetic articulography. Folia Phoniatr 45: 84-89
40. Hoodin RB, Gilbert HR (1989) Nasal airflows in parkinsonian speakers. J Commun Disord 22/3: 169-180
41. Hoodin RB, Gilbert HR (1989) Parkinsonian dysarthria: an aerodynamic and perceptual description of velopharyngeal closure for speech. Folia Phoniatr 41: 249-258
42. Monrad-Krohn GH (1947) Dysprosody or altered melody of language. Brain 70: 405-415
43. Volkmann J, Hefter H, Lange HW, Freund HJ (1992) Impairment of temporal organization of speech in basal ganglia diseases. Brain Lang 43/3: 386-399
44. Ludlow CL, Connor NP, Bassich CJ (1987) Speech timing in Parkinson's and Huntington's disease. Brain Lang 32/2: 195-214
45. Pitcairn TK, Clemie S, Gray JM, Pentland B (1990): Impressions of parkinsonian patients from their recorded voices. Br J Disord Commun 25/1: 85-92
46. Illes J, Metter EJ, Hanson WR, Iritani S (1988) Language production in Parkinson's disease: acoustic and linguistic considerations. Brain Lang 33/1: 146-160
47. Hirose H, Kiritani S, Ushijima T, Yoshioka H, Sawashima M (1981) Patterns of dysarthric movements in patients with parkinsonism. Folia Phoniatr 33: 204-215
48. Ackermann H, Ziegler W (1989) Die Dysarthrophonie des Parkinson-Syndroms. Fortschr Neurol Psychiat 57: 149-160
49. Helm NA (1979) Management of palilalia with a pacing board. J Speech Hear Disord 44: 350-353
50. Scott S, Caird FI, Williams BO (1984) Evidence for an apparent sensory speech disorder in parkinson's disease. J Neurol Neurosurg Psychiat 47: 840-843
51. Caekebeke JF, Jennekens-Schinkel A, Van der Linden ME, Buruma OJ, Roos RA (1991) The interpretation of dysprosody in patients with parkinson's disease. J Neurol Neurosurg Psychiat 54: 145-148
52. Lieberman AN, Horowitz L, Redmond P, Pachter L, Liebermann I, Leibowitz M (1980) Dysphagia in Parkinson's disease. Am J Gastroenterol 74/2: 157-160
53. Johnston BT, Li Q, Castell JA, Castell Do (1995) Swallowing and oesophageal function in Parkinson's disease. Am J Gastroenterol 90/10: 1741-1746
54. Bushmann M, Dobmeyer S, Leeker L, Perlmutter J (1989) Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology 39: 1309-1314
55. Bird MR, Woodward MC, Gibson EM, Phyland DJ, Fonda D (1994) Asymptomatic swallowing disorders in elderly patients with parkinson's disease: a description of findings on clinical exaamination and videofluoroscopy in sixteen patients. Age Ageing 23/3: 251-254
56. Wintzen AR, Badrising UA, Roos RA, Vielvoye J, Liauw L, Pauwels EK (1994) Dysphagia in ambulant patients with parkinson's disease: common, not dangerous. Can J Neurol Sci 21/1: 53-56
57. Robbins JA, Logemann JA, Kirshner Hs (1986) Swallowing and speech production in Parkinson's disease. Ann-Neurol 19/3: 283-287
58. Kurihara K, Kita K, Hirayama K, Hara T (1993) Dysphagia in Parkinson disease (absract). Rinsho Shinkeigaku 33/2: 150-154
59. Stroudley J, Walsh M (1991) Radiological assessment of dysphagia in Parkinson's disease. Br J Radiol 64 (766): 890-893
60. Kennedy G, Pring T, Fawcus R (1993) No place for motor speech acts in the assessment of dysphagia? Intelligibility and swallowing difficulties in stroke and Parkinson's disease patients. Eur J Disord Comm 28: 213-226
61. Allan CM (1970) Treatment of nonfluent speech resulting from neurological disease - treatment of dysarthria. Br J Disord Comm 5: 3-5
62. Perry AR, Das PK (1981) Speech assessment of patients with Parkinson's disease. In: Rose CF, Capildeo R (eds) Research progress in Parkinson's disease. Pitman Medical, London, pp 373-383
63. Scott S, Caird FI (1981) Speech therapy for patients with Pparkinson's disease. BMJ 283: 1088
64. Scott S, Caird FI (1983) Speech therapy for Parkinson's disease. J Neurol Neurosurg Psychiat 46: 140-144
65. Scott S, Claire FI (1984) The response of the apparent receptive speech disorder of Parkinson's disease to speech therapy. J Neurol Neurosurg Psychiat 47: 302-304
66. Robertson SJ, Thomson F (1984) Speech therapy in Parkinson's disease: a study of the efficacy and long term effects of intensive treatment. Br J Disord Comm 19: 213-224
67. Johnson JAS. Pring TR (1990) Speech therapy and Parkinson's disease: a review. Br J Disord Comm 25: 183-194
68. Ramig LO, Boniatati CM, Lemke JH, Horii Y (1994) Voice treatment for patients with Parkinson disease: Development of an approach and preliminary efficacy data. J Med Speech Lang Pathol 2/3: 191-209
69. Ramig LO, Countryman S, O'Brien C, Hoehn M, Thompson L (1996) Intensive speech treatment for patients with parkinson disease: short- and long-term comparison of two techniques. Neurology 47/6: 1496-1504
70. Raming LO, Countryman S, Thompson LL, Horii Y (1995) Comparison of two forms of intensive speech treatment for Parkinson's disease. J Speech Hear Res 38: 1232-1251
71. Smith MS, Ramig LO, Dromey C, Perez KS, Samandari R (1995) Intensive voice treatment in Parkinson's disease: Laryngostroboscic findings. J Voice 9/4: 453-459
72. Ramig LO, Horii Y, Boniati C (1991) The effectiveness of speech therapy for patients with Parkinson's disease. National Center for Voice and Speech Research Report 1: 61-86
73. Countryman S, Ramig LO (1993) Effects of intensive voice therapy on voice deficits associated with bilateral thalamotomy in parkinson disease: a case study. J Med Speech Lang Pathol 1: 233-249
74. Ramig LO, Mead C, Scherer R, Horii Y, Larson K, Kohler D (1988) Voice therapy and Parkinson's disease: a longitudinal study of efficiacy. Paper presented at the Clinical Dysarthria Conference, San Diego, CA
75. Ramig LO, Countryman S, O'Brien C, Smith M (Mai 1995) Efficacy of voice treatment for Parkinson disease. Paper presented to the annual meeting of the American Academy of Neurology, Seattle, WA
76. Countryman S, Ramig LO, Pawlas AA (1994) Speech and voice deficits in parkinsonian plus syndromes: can they be treated? J Med Speech Lang Path 2/3: 211-225
77. Ramig LO (1995) Speech therapy for patients with Parkinson's disease. In: Koller WC, Paulson G (eds) Therapy of Parkinson's disease. Dekker, New York, pp 539-550
78. King JB, Raming LO, Lemke JH, Horit Y (1994) Parkinson's disease: longitudinal changes in acoustic parameters of phonation. J Med Speech Lang Path 2/1: 29-42
79. Rubow R, Swift E (1985) A microcomputer-based wearable biofeedback device to improve transfer of treatment in parkinsonian dysarthria. J Speech Hear Disord 50: 178-185
80. Downie AW, Low JM, Lindsay DD (1981) Speech disorder in Parkinsonism - Usefulness of delayed auditory feedback in selected cases. Br J Disord Comm 16/2: 135-39
81. Lang AE, Fishbein B (1983) The "pacing board" in selected speech disorders of Parkinson's disease. J Neurol Neurosurg Psychiat 46: 789-791
82. Weiner WJ, Singer C (1989) Parkinson's disease and nonpharmacologic treatment programs. JAGS 37: 359-363
83. Wolfe VI, Garvin JS, Bacon M, Waldrop W (1975) Speech changes in Parkinson's disease during treatment with L-Dopa. J Commun Disord 8/3: 271-279
84. Leanderson R, Persson A, Ohman S (1970) Electromyographic studies of the function of the facial muscles in dysarthria. Acta Otolaryngol [Suppl] 263: 89-94
85. Nakano KK, Zubick H, Tyler HR (1973) Speech defects of parkinsonian patients. Neurology 23: 865-870
86. Shea BR, Drummond SS, Metzer WS, Krueger KM (1993) Effect of selegiline on speech performance in Parkinson's disease. Folia Phoniatr Basel 45/1: 40-46
87. Biary N, Pimentai PA, Langenberg PW (1988) A double-blind trial of clonacepam in the treatment of parkinsonian dyarthria. Neurology 38: 255-258
88. Flint AJ, Black SE, Campbell-Taylor I, Gailey GF. Levinton C (1993) Abnormal speech articulation, psychomotor retardation, and subcortical dysfunction in major depression. J Psychiatr Res 27/3: 309-319
89. Flint AJ, Black SE, Campbell-Taylor I, Gailey GF, Levinton C (1992) Acoustic analysis in the differentiation of Parkinson's disease and major depression. J Psycholinguist Res 21 5: 383-389
90. Enderby P, Emerson J (1996) Speech and language therapy: does it work? BMJ 312: 1655-1658
91. Pearson VAH (1995): Speech and language therapy: is it effective? Public Health 109: 143-153